Thorne Phosphatidylserine

Thorne Phosphatidylserine (formerly Iso-Phos) Promotes healthy brain function, supports memory and focus, and modulates cortisol during stress Thorne's Phosphatidylserine contains phosphatidylserine (PS), the primary phospholipid in brain cell membranes. PS improves cell communication to support memory and focus and helps regulate cortisol during stress. Phosphatidylserine (PS) is essential for healthy brain cell membranes and to maintain an environment required for optimal brain function.* Phosphatidylserine improves cell-to-cell communication in the brain, and thus cognitive function, at least in part by increasing cell membrane fluidity.* Other mechanisms of action include enhancing cell metabolism (such as glucose utilization) and neurotransmitter formation.* Phosphatidylserine also appears to have antioxidant activity, which would protect brain cells from free radicals.* Abundant clinical research has shown this nutrient is important in promoting optimal cognitive function, particularly in the aging brain. Studies show supplementing with phosphatidylserine can lower cortisol spikes in response to stress.* PS modulates cortisol by blunting the release of the hormone in the brain (ACTH) that normally signals the adrenal glands to secrete cortisol.* Key Ingredients Phosphatidylserine Other Ingredients: Hypromellose Capsule, Leucine, Microcrystalline Cellulose, Silicon Dioxide Ingredient Amounts Serving Size: 1 Capsules Servings Per Container: 60 Take 1 capsule two to three times daily or as recommended by your health professional. Warnings ALLERGY WARNING This product is contraindicated in an individual with a history of hypersensitivity to any of its ingredients. Phosphatidylserine contains an ingredient derived from soy. Phosphatidylserine contains no soy protein. There are no other soy-based ingredients in Phosphatidylserine. PREGNANCY If pregnant, consult your health professional before using this product. INTERACTIONS/CONTRAINDICATIONS There are no known adverse interactions or contraindications at publication date.